DeaLive

Prediction of side effects in cancer treatment and management of symptoms, along with nutritional support.

DeaLive operates in insurtech based in Tokyo, Japan.

Profile

"DeaLive is an innovative Insurtech company focused on predicting side effects in cancer treatment and managing symptoms, while providing nutritional support. By constructing individual digital models for patients undergoing outpatient anticancer treatment, DeaLive utilizes various factors such as cancer type, drug type, genetic characteristics, and procedures to simulate and predict side effects onset. Through these simulations, DeaLive aims to enhance treatment efficiency and alleviate the psychological burden on patients and their families by offering tailored symptom management, nutritional support, and interventions at home. DeaLive's applications include establishing digital patient models, recording daily side effects, and providing personalized support through remote online consultations with professional staff. This approach revolutionizes cancer care by leveraging technology to improve patient outcomes and quality of life."

DeaLive is positioned in insurtech, a segment that rewards a clear, focused offering.

Tokyo, Japan is where the company is located.

Directory data places it at the Plug and Play portfolio startup stage.

Website: allmylife-jp.com